Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panitumumab with Docetaxel and Cisplatin in Advanced Gastric Cancer
NCT01379807Phase 2Unknown
- Sponsor
- Grupo Oncológico Gallego
- Start
- Dec 2010
- Primary completion
- Dec 2014
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of panitumumab in gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, sponsored by Grupo Oncológico Gallego. Status: unknown.
02
Drugs
panitumumab
03
Conditions
gastric adenocarcinomagastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT01379807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01379807.